Developed as a predictive biomarker, the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay detects the folate receptor 1 protein (FOLR1 or FRÉ‘), which is over-expressed in most ovarian cancers. The new test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback